2023 Q2 Form 10-Q Financial Statement

#000149315223017463 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $20.45M $27.82M $26.32M
YoY Change -15.54% 5.69% 33.27%
Cost Of Revenue $16.56M $22.10M $20.19M
YoY Change -9.12% 9.43% 17.99%
Gross Profit $3.886M $5.722M $6.128M
YoY Change -35.09% -6.63% 132.47%
Gross Profit Margin 19.01% 20.57% 23.28%
Selling, General & Admin $5.315M $6.766M $6.476M
YoY Change -24.84% 4.48% 45.92%
% of Gross Profit 136.77% 118.25% 105.68%
Research & Development $559.0K $423.0K $523.0K
YoY Change 19.44% -19.12% 5.87%
% of Gross Profit 14.38% 7.39% 8.53%
Depreciation & Amortization $96.00K $108.0K $538.0K
YoY Change 65.52% -79.93% -5.28%
% of Gross Profit 2.47% 1.89% 8.78%
Operating Expenses $6.392M $7.733M $7.537M
YoY Change -20.14% 2.6% 37.04%
Operating Profit -$2.506M -$2.011M -$1.409M
YoY Change 24.24% 42.73% -50.8%
Interest Expense $740.0K $938.0K -$812.0K
YoY Change -15.72% -215.52% 37.86%
% of Operating Profit
Other Income/Expense, Net -$1.461M -$1.689M -$264.0K
YoY Change 15.31% 539.77% -340.0%
Pretax Income -$3.967M -$3.700M -$2.485M
YoY Change 20.8% 48.89% -25.67%
Income Tax -$101.0K -$193.0K $84.00K
% Of Pretax Income
Net Earnings -$3.866M -$3.507M -$2.569M
YoY Change 21.34% 36.51% -23.15%
Net Earnings / Revenue -18.91% -12.61% -9.76%
Basic Earnings Per Share -$0.49 -$0.45 -$0.34
Diluted Earnings Per Share -$0.49 -$0.45 -$350.9K
COMMON SHARES
Basic Shares Outstanding 7.886M shares 7.883M shares 7.511M shares
Diluted Shares Outstanding 7.778M shares 7.750M shares 7.511M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.998M $3.230M $6.922M
YoY Change -31.5% -53.34% 159.35%
Cash & Equivalents $1.998M $3.230M $6.922M
Short-Term Investments
Other Short-Term Assets $371.0K $729.0K $1.453M
YoY Change 3610.0% -49.83% 124.92%
Inventory $6.685M $8.885M $7.517M
Prepaid Expenses $1.261M $1.632M
Receivables $18.28M $25.65M $29.79M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $28.60M $40.13M $45.68M
YoY Change -27.27% -12.16% 167.3%
LONG-TERM ASSETS
Property, Plant & Equipment $1.373M $1.361M $4.287M
YoY Change 52.05% -68.25% 1252.37%
Goodwill $16.43M $16.48M
YoY Change -0.53%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.202M $1.620M $1.630M
YoY Change -30.76% -0.61% 3780.95%
Total Long-Term Assets $27.17M $28.35M $31.25M
YoY Change -10.73% -9.3% 47.96%
TOTAL ASSETS
Total Short-Term Assets $28.60M $40.13M $45.68M
Total Long-Term Assets $27.17M $28.35M $31.25M
Total Assets $55.77M $68.47M $76.93M
YoY Change -20.05% -11.0% 101.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $52.86M $58.22M $48.35M
YoY Change 2.54% 20.41% 41.89%
Accrued Expenses $2.528M $3.527M $4.669M
YoY Change -40.73% -24.46% 234.46%
Deferred Revenue
YoY Change
Short-Term Debt $2.990M $5.225M $7.353M
YoY Change -31.48% -28.94%
Long-Term Debt Due $9.038M $11.04M $7.937M
YoY Change 19.58% 39.07% 16.05%
Total Short-Term Liabilities $68.85M $79.74M $70.99M
YoY Change -1.53% 12.33% 62.48%
LONG-TERM LIABILITIES
Long-Term Debt $1.570M $44.00K $3.323M
YoY Change -44.19% -98.68% 468.03%
Other Long-Term Liabilities $178.0K $314.0K $2.165M
YoY Change 29.93% -85.5% 69.54%
Total Long-Term Liabilities $178.0K $314.0K $5.488M
YoY Change 29.93% -94.28% 194.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $68.85M $79.74M $70.99M
Total Long-Term Liabilities $178.0K $314.0K $5.488M
Total Liabilities $71.68M $81.31M $78.92M
YoY Change -3.99% 3.03% 73.25%
SHAREHOLDERS EQUITY
Retained Earnings -$92.00M -$88.00M
YoY Change 20.13%
Common Stock $8.000K $8.000K
YoY Change -60.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$15.91M -$12.84M -$1.985M
YoY Change
Total Liabilities & Shareholders Equity $55.77M $68.47M $76.93M
YoY Change -20.05% -11.0% 101.33%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$3.866M -$3.507M -$2.569M
YoY Change 21.34% 36.51% -23.15%
Depreciation, Depletion And Amortization $96.00K $108.0K $538.0K
YoY Change 65.52% -79.93% -5.28%
Cash From Operating Activities $522.0K -$1.289M -$775.0K
YoY Change -77.42% 66.32% -130.89%
INVESTING ACTIVITIES
Capital Expenditures $341.0K -$41.00K
YoY Change -931.71% 1950.0%
Acquisitions
YoY Change
Other Investing Activities $572.0K $0.00 -$23.00K
YoY Change -115.6% -100.0% -104.07%
Cash From Investing Activities $913.0K -$341.0K -$64.00K
YoY Change -124.64% 432.81% -111.37%
FINANCING ACTIVITIES
Cash Dividend Paid $1.346M
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.317M $3.000M 968.0K
YoY Change -21.93% 209.92% -119.15%
NET CHANGE
Cash From Operating Activities 522.0K -$1.289M -775.0K
Cash From Investing Activities 913.0K -$341.0K -64.00K
Cash From Financing Activities -2.317M $3.000M 968.0K
Net Change In Cash -882.0K $1.370M 129.0K
YoY Change -79.78% 962.02% -106.51%
FREE CASH FLOW
Cash From Operating Activities $522.0K -$1.289M -$775.0K
Capital Expenditures $341.0K -$41.00K
Free Cash Flow -$1.630M -$734.0K
YoY Change 122.07% -129.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000278165
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
CY2023Q1 OMQS Net Income After Noncommon Stockholder Dividends Attributable To Noncontrolling Interest
NetIncomeAfterNoncommonStockholderDividendsAttributableToNoncontrollingInterest
usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
CY2022Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
CY2023Q1 OMQS Proceeds From Repayments Of Sale Of Other Productive Assets
ProceedsFromRepaymentsOfSaleOfOtherProductiveAssets
usd
CY2023Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
usd
CY2023Q1 us-gaap Stock Issued1
StockIssued1
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-09047
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
OMNIQ Corp.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-3454263
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1865 West 2100 South
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Salt Lake City
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84119
CY2023Q1 dei City Area Code
CityAreaCode
(801)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
242-7272
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
OMQS
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7885802 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3230000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1311000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
25649000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23893000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
8885000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
8726000 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1632000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1268000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
729000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
473000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
40125000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
35671000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1030000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1030000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1361000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1086000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
16483000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
16542000 usd
CY2023Q1 us-gaap Finite Lived Trade Names Gross
FiniteLivedTradeNamesGross
1670000 usd
CY2022Q4 us-gaap Finite Lived Trade Names Gross
FiniteLivedTradeNamesGross
1826000 usd
CY2023Q1 us-gaap Finite Lived Customer Relationships Gross
FiniteLivedCustomerRelationshipsGross
4604000 usd
CY2022Q4 us-gaap Finite Lived Customer Relationships Gross
FiniteLivedCustomerRelationshipsGross
4967000 usd
CY2023Q1 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
621000 usd
CY2022Q4 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
675000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1986000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2300000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
1620000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
1744000 usd
CY2023Q1 us-gaap Assets
Assets
68470000 usd
CY2022Q4 us-gaap Assets
Assets
64811000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
58216000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
54736000 usd
CY2023Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
5225000 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1971000 usd
CY2023Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
2637000 usd
CY2022Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
2633000 usd
CY2023Q1 OMQS Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
195000 usd
CY2022Q4 OMQS Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
293000 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
10843000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
11572000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
890000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
942000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1733000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1394000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
79739000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
73541000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
72000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
72000 usd
CY2023Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
44000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
55000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1141000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1404000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
314000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
265000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
81310000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
75337000 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7884878 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7884878 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7714780 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7714780 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
8000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
8000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
74458000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
73714000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-87975000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-84460000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
668000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
211000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-12840000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-10526000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
68470000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
64811000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27821000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26322000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
22099000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20194000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
5722000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
6128000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
423000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
523000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6766000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6476000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
108000 usd
CY2022Q1 us-gaap Depreciation
Depreciation
93000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
436000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
445000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
7733000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
7537000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2011000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1409000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
938000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
812000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-751000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-264000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1689000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1076000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3700000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2485000 usd
CY2023Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-193000 usd
CY2022Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
84000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-193000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
84000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-3507000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-2569000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
67000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3507000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2636000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-3507000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-2569000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
457000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-10000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-3050000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2579000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-3507000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-2569000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
8000 usd
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
48000 usd
CY2022Q1 OMQS Net Income After Noncommon Stockholder Dividends Attributable To Noncontrolling Interest
NetIncomeAfterNoncommonStockholderDividendsAttributableToNoncontrollingInterest
67000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3515000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2684000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7749870 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7511376 shares
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2298000 usd
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
48000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
8000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
298000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
460000 usd
CY2022Q1 OMQS Stock Issued During Period Value Exercise Of Stock Options And Warrants
StockIssuedDuringPeriodValueExerciseOfStockOptionsAndWarrants
41000 usd
CY2022Q1 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-30000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-2569000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
458000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-10526000 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
8000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
10000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
45000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
516000 usd
CY2023Q1 OMQS Stock Issued During Period Value Exercise Of Stock Options And Warrants
StockIssuedDuringPeriodValueExerciseOfStockOptionsAndWarrants
173000 usd
CY2023Q1 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
457000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-3507000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-12840000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-3507000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-2569000 usd
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-46000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
516000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
460000 usd
CY2023Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
45000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
544000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
538000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
281000 usd
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
222000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2228000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2641000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
384000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-506000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
395000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
678000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-104000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
167000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3954000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3017000 usd
CY2023Q1 OMQS Increase In Accounts Payable And Accrued Liabilities Related Party
IncreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty
1000 usd
CY2022Q1 OMQS Increase In Accounts Payable And Accrued Liabilities Related Party
IncreaseInAccountsPayableAndAccruedLiabilitiesRelatedParty
5000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
91000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
737000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-282000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-220000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
37000 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
65000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
8000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
34000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1289000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-775000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
341000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
41000 usd
CY2022Q1 OMQS Proceeds From Repayments Of Sale Of Other Productive Assets
ProceedsFromRepaymentsOfSaleOfOtherProductiveAssets
-23000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-341000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-64000 usd
CY2023Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
10000 usd
CY2022Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
8000 usd
CY2023Q1 OMQS Proceeds From Exercise Of Options And Warrants
ProceedsFromExerciseOfOptionsAndWarrants
173000 usd
CY2022Q1 OMQS Proceeds From Exercise Of Options And Warrants
ProceedsFromExerciseOfOptionsAndWarrants
41000 usd
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
1346000 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-544000 usd
CY2022Q1 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
566000 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
3361000 usd
CY2022Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1699000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
968000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1370000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
130000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
549000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-292000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1311000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7085000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3230000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6922000 usd
CY2023Q1 OMQS Declared Dividends Payable
DeclaredDividendsPayable
8000 usd
CY2022Q1 OMQS Declared Dividends Payable
DeclaredDividendsPayable
180000 usd
CY2022Q1 us-gaap Stock Issued1
StockIssued1
298000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
938000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
1105000 usd
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7749870 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7511376 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3389317000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3600484000 shares
CY2023Q1 OMQS Working Capital Deficit
WorkingCapitalDeficit
39600000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-88000000 usd
CY2023Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
827000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
649000 usd
CY2023Q1 us-gaap Other Inventory In Transit
OtherInventoryInTransit
2062000 usd
CY2022Q4 us-gaap Other Inventory In Transit
OtherInventoryInTransit
2004000 usd
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5996000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6073000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
8885000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
8726000 usd
CY2023Q1 us-gaap Other Notes Payable
OtherNotesPayable
10887000 usd
CY2022Q4 us-gaap Other Notes Payable
OtherNotesPayable
11627000 usd
CY2023Q1 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
10843000 usd
CY2022Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
11572000 usd
CY2023Q1 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
44000 usd
CY2022Q4 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
55000 usd
CY2021Q3 us-gaap Loans Payable
LoansPayable
500000
CY2021Q3 us-gaap Loans Payable
LoansPayable
155000 usd
CY2021Q3 us-gaap Debt Instrument Term
DebtInstrumentTerm
P5Y
CY2021Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.075 pure
CY2022Q1 us-gaap Loans Payable
LoansPayable
292000
CY2022Q1 us-gaap Loans Payable
LoansPayable
81000 usd
CY2022Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
26800000
CY2022Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
7600000 usd
CY2022Q4 us-gaap Short Term Debt Weighted Average Interest Rate
ShortTermDebtWeightedAverageInterestRate
0.063 pure
CY2023Q1 us-gaap Accounts Payable Trade Current And Noncurrent
AccountsPayableTradeCurrentAndNoncurrent
803000 usd
CY2022Q4 us-gaap Accounts Payable Trade Current And Noncurrent
AccountsPayableTradeCurrentAndNoncurrent
801000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
159000 usd
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
153000 usd
CY2023Q1 us-gaap Other Sundry Liabilities
OtherSundryLiabilities
1085000 usd
CY2022Q4 us-gaap Other Sundry Liabilities
OtherSundryLiabilities
705000 usd
CY2023Q1 us-gaap Other Liabilities
OtherLiabilities
2047000 usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
1659000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1733000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1394000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
314000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
265000 usd
CY2023Q1 us-gaap Accrued Liabilities For Commissions Expense And Taxes
AccruedLiabilitiesForCommissionsExpenseAndTaxes
60000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
omqs-20230331_cal.xml Edgar Link unprocessable
omqs-20230331_def.xml Edgar Link unprocessable
0001493152-23-017463-index-headers.html Edgar Link pending
0001493152-23-017463-index.html Edgar Link pending
0001493152-23-017463.txt Edgar Link pending
0001493152-23-017463-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
omqs-20230331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
omqs-20230331_lab.xml Edgar Link unprocessable
omqs-20230331_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending